Twitter | Search | |
endTB
, & . A new partnership to change MDR-TB treatments around the world.
334
Tweets
179
Following
1,256
Followers
Tweets
endTB retweeted
IRD Nov 5
and announced the start of a clinical trial in Pakistan that aims to find better, shorter treatments against multidrug-resistant forms of tuberculosis (MDR-TB) using new TB drugs developed in recent years. For more information, visit .
Reply Retweet Like
endTB Nov 4
We are pleased to start the endTB Clinical Trial in Karachi, Pakistan, with and .
Reply Retweet Like
endTB retweeted
carole mitnick Nov 4
Esteemed ⁦⁩ & faculty at symposium on operational research for all-oral, short regimens for MDR. THE ⁦⁩ platform built for ⁦⁩ is a strong foundation for new efforts & will further enhance evidence for improved MDR-TB treatment.
Reply Retweet Like
endTB retweeted
carole mitnick Nov 1
Transparent & reduced prices, <$1/day, of delamanid, pretomanid, bedaquiline are essential. Life-saving drugs are not a luxury. ⁦⁩ ⁦⁩ ⁦ ⁦⁦
Reply Retweet Like
endTB retweeted
Molly Franke Nov 1
Bedaquiline and delamanid are safe. The ⁦⁩ team presents reassuring results from our 17-country multisite observational study. ⁦⁩ ⁦⁩ ⁦⁩ ⁦
Reply Retweet Like
endTB retweeted
Partners In Health Nov 1
. has been participating in the this week--the world’s foremost conference addressing tuberculosis--pushing to combat TB, the world’s deadliest infectious disease through .
Reply Retweet Like
endTB Oct 31
We were happy to present brand-new results from observational study during our symposium at . Learn more about endTB project on
Reply Retweet Like
endTB retweeted
carole mitnick Oct 30
Replying to @endTB @UNITAID
Brand-new results from the observational study will also be presented. Learn more about the supported project at or .
Reply Retweet Like
endTB retweeted
Patrick Phillips Oct 31
Impressive end of treatment outcomes from observational study: 77.6%, comparable to trials. Fantastic example of how to generate data that can change policy and practice in the absence of trials.
Reply Retweet Like
endTB retweeted
Unitaid Oct 30
Today Unitaid’s & chaired session “Paving the way for innovations to end epidemic”, discussing 4 Unitaid grants: faster Dx, better & simpler treatments, including for kids w/ MDR-TB & digital adherence technologies for treatments
Reply Retweet Like
endTB Oct 30
Dr. Lorenzo Guglielmetti presenting the endTB Project during 's workshop "Paving the way for innovations to end the TB epidemic" at
Reply Retweet Like
endTB retweeted
carole mitnick Sep 30
Cathy Hewison presenting results at . 77% provisional favorable outcomes and <3% QT prolongation in largest multi-country cohort of MDR-TB patients to receive bedaquiline &/or delamanid.
Reply Retweet Like
endTB retweeted
carole mitnick Aug 21
New pub by ⁦-supported ⁩ ⁦⁩. Protocol for following largest group of patients w/resistant TB to receive bedaquiline or delamanid. More to follow on 17-country cohort from ⁦⁦⁩, ⁦⁩, ⁦⁦⁩.
Reply Retweet Like
endTB Mar 26
Find Dr Jay Achar's editorial blog post about one of the major issues faced by the TB community. "Progress in Peril: Stagnant Funding Could Lengthen the TB Elimination Timeline"
Reply Retweet Like
endTB Mar 24
Tuberculosis is world's deadliest infectious disease, is working hard to improve MDR-TB treatment. On World TB day, we are pleased to celebrate the first endTB trial participant to complete the trial follow-up.
Reply Retweet Like
endTB retweeted
MSF_TB 20 Aug 18
MSF calls on , producers of bedaquiline, to take immediate steps to make the drug affordable for all those who need it - especially those in low and middle income countries with the highest burden of DR-TB.
Reply Retweet Like
endTB retweeted
MSF_TB 17 Aug 18
The newly recommended regimen for treating DR-TB which focuses on oral drugs over injectables can help improve cure rates, decrease mortality and has far fewer side effects than older regimens - see MSF response:
Reply Retweet Like
endTB 15 Jul 18
The latest TB drugs are safe and effective. So why are so few patients getting them? And why are we still prioritising the toxic injectables instead? The evidence is clear, so let's heed the evidence. More in :
Reply Retweet Like
endTB retweeted
Patricia Kahn 13 Jul 18
Evidence is increasingly clear: new drugs & are safe, successful alternatives to more toxic -TB treatment. Improved guidance + focused efforts CAN overcome hurdles to wider use.
Reply Retweet Like
endTB 15 Jul 18
The times they're a-changing... New research from , , and partners indicate new TB drugs are - safe - effective - will play a larger role in TB care Find out more in our blog
Reply Retweet Like